William Meury, Chief Commercial Officer at Allergan plc (AGN), sold 58,879 shares at $157.18 ($9.5M) on 2018-02-14, disclosed to the SEC on 2018-02-16.
Open-market sale of $9.5M AGN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.18 | 25,079 | $3.9M | 41.7% |
| 2 | $157.60 | 1,200 | $189K | 2.0% |
| 3 | $158.78 | 1,700 | $270K | 2.9% |
| 4 | $159.82 | 2,400 | $384K | 4.1% |
| 5 | $161.10 | 1,000 | $161K | 1.7% |
| 6 | $162.22 | 4,700 |
| $762K |
| 8.1% |
| 7 | $163.04 | 7,200 | $1.2M | 12.4% |
| 8 | $164.62 | 2,000 | $329K | 3.5% |
| 9 | $165.16 | 13,600 | $2.2M | 23.8% |
| Total | $160.62 avg | 58,879 | $9.5M | 100% |
| Filing → |
| AGN | SELL | 2017-12-04 | $4.1M | — | Filing → |
| ACT | SELL | 2014-12-01 | $1.2M | — | Filing → |
| FRX | SELL | 2013-02-08 | $942K | — | Filing → |